Enhanced Analgesic Effects and GI Safety of a Novel Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids
Antioxidants and Redox Signaling - United States
doi 10.1089/ars.2019.7884
Full Text
Open PDFAbstract
Available in full text
Date
March 13, 2020
Authors
Publisher
Mary Ann Liebert Inc